Vimarsana
Biggest News Aggregation in the World

Page 9 - Project Nextgen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Nextgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Nextgen Today - Breaking & Trending Today

First on CNN: HHS awards more than $500 million to study Covid-19 vaccine nasal sprays and more - Vimarsana News

First on CNN: HHS awards more than $500 million to study Covid-19 vaccine nasal sprays and more

(CNN) — In the future, some Covid-19 vaccines may not be jabs in the arm. They could be a nasal spray or even a patch on the skin. Those are

Source: kdrv.com
Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio's BARDA Award - Gritstone Bio (NASDAQ:GRTS) - Vimarsana News

Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio's BARDA Award - Gritstone Bio (NASDAQ:GRTS)

VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust and expansive lipid nanoparticle

Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials - Vimarsana News

Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials

NIAID is conducting early phase clinical trials on select next generation vaccine candidates with the intent to identify the most effective platforms and delivery routesOCU500 will be tested as both...

Research Roundup: Combination COVID-19-flu shot, mAbs funding, Second malaria vaccine approval - Vimarsana News

Research Roundup: Combination COVID-19-flu shot, mAbs funding, Second malaria vaccine approval

In today's Research Roundup for October 9, 2023, we highlight some of the most interesting reads in global health research and development from the past week.

Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023 - Vimarsana News

Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023

04.10.2023 - EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) - Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced results from all three (3) Phase 1 studies ... Seite 1